scispace - formally typeset
A

Ann S. Hashimoto

Researcher at University of Hawaii at Manoa

Publications -  6
Citations -  279

Ann S. Hashimoto is an academic researcher from University of Hawaii at Manoa. The author has contributed to research in topics: Colitis & Colorectal cancer. The author has an hindex of 4, co-authored 5 publications receiving 234 citations.

Papers
More filters
Journal ArticleDOI

Selenoprotein K Knockout Mice Exhibit Deficient Calcium Flux in Immune Cells and Impaired Immune Responses

TL;DR: The results establish Sel K as an endoplasmic reticulum-membrane protein important for promoting effective Ca2+ flux during immune cell activation and provide insight into molecular mechanisms by which dietary selenium enhances immune responses.
Journal ArticleDOI

Specific antioxidant selenoproteins are induced in the heart during hypertrophy

TL;DR: The main response of the selenoproteome during hypertrophy does not involve increased GPX1, but increased GPx3 for reducing extracellular H( 2)O(2) and increasedGPx4, Trxrd1, and MsrB1 for minimizing intracellular oxidative damage.
Journal ArticleDOI

Calpastatin Prevents NF-κB–Mediated Hyperactivation of Macrophages and Attenuates Colitis

TL;DR: It is found that calpain levels did not differ between intestinal tissues from inflammatory bowel disease (IBD) patients and healthy controls, but IBD tissues showed increased levels of the endogenous calpain inhibitor, calpastatin (CAST).
Journal ArticleDOI

Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer

TL;DR: Overall, these findings suggest that intervention with a calpain-2 inhibitor may reduce colitis and colitis-associated cancer through a two-hit process of limiting macrophage activation and inhibiting growth of the colorectal cancer cells themselves.
Journal ArticleDOI

Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme.

TL;DR: Five human colon cancer cell lines were directly treated with a calpain‐2 inhibitor and results showed increased cell death in 4 of 5 cell lines and decreased anchorage‐independent growth for all cell five lines, suggesting calpain-2 inhibitor treatment may be most effective on colorectal tumors expressing highest levels of calpain•2.